Furthermore, culturing of OVA-specific CD8+ T-cells on this SIN elevates the cellular levels of granzyme B expressed by these cells and increases their efficiency in killing ovalbumin-expressing cultured cancer cells, as well as their tumor suppressive activity, in vivo (1). This evidence concerns the gene CD8A and cancer.